Our global partnerships are the key to growth
2021 was a year with many bright spots but also certain challenges. Despite a challenging external environment, we had our second best-year-ever in terms of sales. During the year, we entered into a number of global partnerships that will be important for us to achieve our growth goals in the future.
Our manufacturing facilities have received a major upgrade, which is the key to both improved profitability and a more efficient use of resources. During the year, we formulated a clear sustainability strategy that is integrated with our three strategic focus areas.
”It’s an honor to have some of the world’s largest healthcare companies choose us, Probi, as their partner for scientifically proven probiotics.”
Net Sales SEK m
Operating profit SEK m
EBITDA margin (1)
Market and products
Globally, retail sales of probiotic supplements amounted to nearly USD 7 bn in 2021.
The largest market was the United States, where the value of probiotic supplements amounted to approximately USD 2.3 bn in 2021. The US market accounted for just under 35% of the global market. The second largest market was China, which has grown in recent years and amounted to approximately USD 900 m in 2021. Italy is the third largest market with a value of USD 673 m.
Global sales of probiotic supplements
Region Americas, 34%
Region APAC, 34%
Region EMEA, 27%
Rest of world, 5%
Probi net sales per market
Region Americas, 74%
Region EMEA, 19%
Region APAC, 7%
Probi sales per category
Product sales, 98%
Growth in net sales region EMEA
Number of new global key customers in 2021
Net sales growth YoY
Number of patents
43 new patents were approved in 2021
Published studies in 2021
Studies within iron health, bone health and tolerance study on newborn babies
Investments in R&D
Investments in research and development 2021, corresponding to 6% of net sales
Investments in increased efficiency have contributed to reduced water consumption in production.
Probi has two production facilities in the USA.
Our vision is to improve the health and well-being of people around the world
The starting point of Probi’s new sustainability strategy is the company’s vision to improve the health and well-being of people throughout the world. In Probi’s day-to-day work – from probiotics research to manufacturing and new collaborations – a significant part of the sustainability work already takes place.
The aim of the strategy is to ensure that sustainability efforts take place in all parts of the business and as strategically as Probi’s business development in other spheres.
The work on sustainability in three key areas, in which Probi has set ambitions, targets and an action plan.
Number of countries in which Probi's products are sold
With establishment in more markets, Probi contributes to increased prosperity in the world through sales of clinically documented probiotics.
of suppliers to whom the Code of Conduct was sent signed it
By 2025, all our suppliers will adhere to the established principles of safety, security, diverse and inclusive environments for employees.
Reduced CO2 emissions
We reduced our CO2 emissions by 10% in 2021 compared to 2020. Our ambition is to halve CO2 emissions throughout our value chain by 2030.
Gender distribution, managers
Gender distribution, executive mgmt